1. Home
  2. RDY vs COKE Comparison

RDY vs COKE Comparison

Compare RDY & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • COKE
  • Stock Information
  • Founded
  • RDY 1984
  • COKE 1980
  • Country
  • RDY India
  • COKE United States
  • Employees
  • RDY N/A
  • COKE N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • COKE Beverages (Production/Distribution)
  • Sector
  • RDY Health Care
  • COKE Consumer Staples
  • Exchange
  • RDY Nasdaq
  • COKE Nasdaq
  • Market Cap
  • RDY 13.1B
  • COKE 11.3B
  • IPO Year
  • RDY N/A
  • COKE N/A
  • Fundamental
  • Price
  • RDY $79.49
  • COKE $1,265.48
  • Analyst Decision
  • RDY Buy
  • COKE
  • Analyst Count
  • RDY 1
  • COKE 0
  • Target Price
  • RDY $87.00
  • COKE N/A
  • AVG Volume (30 Days)
  • RDY 156.2K
  • COKE 31.2K
  • Earning Date
  • RDY 10-29-2024
  • COKE 10-30-2024
  • Dividend Yield
  • RDY 1.20%
  • COKE 0.28%
  • EPS Growth
  • RDY 17.48
  • COKE 6.40
  • EPS
  • RDY 4.00
  • COKE 54.05
  • Revenue
  • RDY $3,460,984,788.00
  • COKE $6,730,953,000.00
  • Revenue This Year
  • RDY $13.21
  • COKE N/A
  • Revenue Next Year
  • RDY $8.56
  • COKE N/A
  • P/E Ratio
  • RDY $19.79
  • COKE $23.58
  • Revenue Growth
  • RDY 10.49
  • COKE 3.36
  • 52 Week Low
  • RDY $63.72
  • COKE $625.77
  • 52 Week High
  • RDY $84.46
  • COKE $1,376.84
  • Technical
  • Relative Strength Index (RSI)
  • RDY 46.19
  • COKE 44.09
  • Support Level
  • RDY $78.40
  • COKE $1,263.63
  • Resistance Level
  • RDY $80.00
  • COKE $1,320.00
  • Average True Range (ATR)
  • RDY 0.86
  • COKE 22.10
  • MACD
  • RDY 0.11
  • COKE -2.13
  • Stochastic Oscillator
  • RDY 58.28
  • COKE 19.81

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc sells nonalcoholic beverage products in the United States. The company purchases concentrate and syrups from other beverage manufacturers under a license, then produces, packages, markets, and distributes the beverages to retailers. The company's primary licensor is Coca-Cola Co., which generally allows it to exclusively market, produce, and distribute Coca-Cola products in specified parts of the U.S.: North Carolina, South Carolina, West Virginia, and parts of Alabama, Georgia, Tennessee, Virginia, Indiana, and Kentucky. The company manages its business in two operating segments. Nonalcoholic Beverages segment which represents the majority of the company's revenues and All Other segments.

Share on Social Networks: